ArticleOncotarget2016

Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study.

Masahito Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.